Vaccine
stringclasses 11
values | Dose
stringclasses 9
values | Geography Type
stringclasses 2
values | Geography
stringclasses 79
values | Birth Year/Birth Cohort
stringclasses 21
values | Dimension Type
stringclasses 6
values | Dimension
stringclasses 26
values | Estimate (%)
float64 4.7
100
⌀ | 95% CI (%)
stringlengths 10
13
⌀ | Sample Size
int64 9
63.4k
⌀ |
|---|---|---|---|---|---|---|---|---|---|
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 97.8 | 96.0 to 99.6 | 394 |
≥1 Dose Varicella | null | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 92.5 | 90.2 to 94.7 | 888 |
Rotavirus | null | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 84.7 | 81.7 to 87.7 | 888 |
Hep A | ≥2 Doses | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 83.2 | 79.2 to 87.2 | 888 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 88.8 | 82.4 to 95.2 | 159 |
Hep B | ≥1 Dose, 3 Day (Birth Dose) | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 79.8 | 76.6 to 83.1 | 888 |
Influenza | null | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 71.9 | 68.2 to 75.7 | 888 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 86.2 | 78.9 to 93.5 | 159 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 94.8 | 91.9 to 97.6 | 335 |
Hep A | ≥2 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 83.4 | 77.1 to 89.6 | 335 |
Hep A | ≥1 Dose | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 89.8 | 87.4 to 92.3 | 888 |
Hep A | ≥2 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 89.7 | 84.5 to 95.0 | 394 |
Hep A | ≥1 Dose | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 83.8 | 77.0 to 90.7 | 159 |
PCV | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 88 | 85.3 to 90.8 | 888 |
Hep A | ≥1 Dose | States/Local Areas | New Hampshire | 2016-2019 | Poverty | 133% to <400% FPL | 88.3 | 84.2 to 92.5 | 335 |
≥1 Dose MMR | null | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 94.3 | 92.5 to 96.2 | 888 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Poverty | <133% FPL | 75 | 66.5 to 83.5 | 159 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 93.6 | 91.5 to 95.8 | 888 |
Rotavirus | null | States/Local Areas | New Hampshire | 2016-2019 | Poverty | >400% FPL | 91.8 | 88.4 to 95.3 | 394 |
Polio | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 94.7 | 92.7 to 96.7 | 888 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Overall | Overall | 86.2 | 83.4 to 89.1 | 888 |
Influenza | null | States/Local Areas | New Hampshire | 2016-2019 | Race and Ethnicity | Hispanic | 74.7 | 63.5 to 85.9 | 67 |
≥1 Dose MMR | null | States/Local Areas | New Hampshire | 2016-2019 | Insurance Coverage | Any Medicaid | 93.4 | 89.9 to 96.9 | 275 |
≥1 Dose MMR | null | States/Local Areas | New Hampshire | 2016-2019 | Insurance Coverage | Private Insurance Only | 96.2 | 94.3 to 98.1 | 563 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Race and Ethnicity | Other or Multiple Races, Non-Hispanic | 93.5 | 87.3 to 99.7 | 72 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Race and Ethnicity | Hispanic | 85.3 | 75.5 to 95.1 | 67 |
≥1 Dose Varicella | null | States/Local Areas | New Hampshire | 2016-2019 | Insurance Coverage | Private Insurance Only | 94 | 91.4 to 96.6 | 563 |
≥1 Dose Varicella | null | States/Local Areas | New Hampshire | 2016-2019 | Race and Ethnicity | Other or Multiple Races, Non-Hispanic | 97.6 | 94.3 to 100.0 | 72 |
Hep A | ≥2 Doses | States/Local Areas | New Hampshire | 2016-2019 | Insurance Coverage | Any Medicaid | 77.2 | 69.2 to 85.3 | 275 |
Hep A | ≥2 Doses | States/Local Areas | New Hampshire | 2016-2019 | Insurance Coverage | Private Insurance Only | 88.6 | 84.3 to 92.8 | 563 |
Polio | ≥1 Dose | States/Local Areas | New Hampshire | 2020 | Age | 3 Months | 92.7 | 86.2 to 96.2 | 189 |
Hib | ≥1 Dose | States/Local Areas | New Hampshire | 2020 | Age | 3 Months | 93.3 | 87.1 to 96.7 | 189 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2020 | Age | 7 Months | 75.6 | 67.4 to 82.2 | 189 |
Hep B | ≥1 Dose | States/Local Areas | New Hampshire | 2020 | Age | 3 Months | 95.5 | 91.2 to 97.7 | 189 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2020 | Age | 24 Months | 96.3 | 92.7 to 98.4 | 189 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2020 | Age | 7 Months | 75.1 | 66.2 to 82.2 | 189 |
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2020 | Age | 13 Months | 96.7 | 93.1 to 98.5 | 189 |
Rotavirus | null | States/Local Areas | New Hampshire | 2019-2020 | Age | 8 Months | 80.9 | 75.5 to 85.3 | 403 |
Hep B | ≥1 Dose, 1 Day | States/Local Areas | New Hampshire | 2021 | Age | 0-1 Days | 77.2 | 67.4 to 84.8 | 126 |
Hib | ≥2 Doses | States/Local Areas | New Hampshire | 2020-2021 | Age | 13 Months | 95.6 | 92.2 to 97.6 | 315 |
Combined 7 Series | null | States/Local Areas | New Hampshire | 2016-2019 | Race and Ethnicity | Other or Multiple Races, Non-Hispanic | 80.4 | 68.6 to 92.1 | 72 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Race and Ethnicity | White, Non-Hispanic | 95.2 | 93.3 to 97.2 | 728 |
≥1 Dose MMR | null | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 88.4 | 81.7 to 95.2 | 165 |
PCV | ≥4 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Principal City | 79.7 | 71.5 to 87.9 | 165 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 95.5 | 92.8 to 98.2 | 384 |
Hep A | ≥2 Doses | States/Local Areas | New Hampshire | 2016-2019 | Urbanicity | Living In a MSA Non-Principal City | 87.4 | 82.0 to 92.7 | 384 |
Hep B | ≥1 Dose, 2 Day | States/Local Areas | New Hampshire | 2021 | Age | 0-2 Days | 79.6 | 69.9 to 86.8 | 126 |
Hib | ≥3 Doses | States/Local Areas | New Jersey | 2011 | Age | 19 Months | 94.7 | 91.3 to 96.9 | 264 |
Hib | ≥3 Doses | States/Local Areas | New Jersey | 2012 | Age | 19 Months | 92 | 88.9 to 94.3 | 288 |
Hib | ≥3 Doses | States/Local Areas | New Jersey | 2019 | Age | 13 Months | 87.2 | 79.7 to 92.2 | 279 |
Hep A | ≥2 Doses | States/Local Areas | New Hampshire | 2021 | Age | 35 Months | 81.7 | 65.5 to 93.4 | 126 |
PCV | ≥4 Doses | States/Local Areas | New Hampshire | 2021 | Age | 19 Months | 85.4 | 76.0 to 91.5 | 126 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 94.7 | 90.3 to 97.6 | 126 |
Hep B | ≥2 Doses | States/Local Areas | New Hampshire | 2020-2021 | Age | 13 Months | 95.1 | 91.7 to 97.1 | 315 |
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2020-2021 | Age | 19 Months | 96.9 | 94.3 to 98.3 | 315 |
≥1 Dose Varicella | null | States/Local Areas | New Hampshire | 2020-2021 | Age | 35 Months | 94.5 | 89.9 to 97.5 | 315 |
Hib | Primary Series | States/Local Areas | New Hampshire | 2021 | Age | 7 Months | 76.8 | 66.7 to 84.6 | 126 |
Hep A | ≥1 Dose | States/Local Areas | New Hampshire | 2021 | Age | 35 Months | 95.2 | 88.0 to 98.7 | 126 |
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2021 | Age | 13 Months | 91.3 | 83.0 to 95.7 | 126 |
Polio | ≥2 Doses | States/Local Areas | New Hampshire | 2021 | Age | 13 Months | 94.2 | 88.2 to 97.3 | 126 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2020-2021 | Age | 35 Months | 95.5 | 92.5 to 97.5 | 315 |
Hep A | ≥1 Dose | States/Local Areas | New Hampshire | 2021 | Age | 19 Months | 91.8 | 84.3 to 95.9 | 126 |
DTaP | ≥1 Dose | States/Local Areas | New Hampshire | 2021 | Age | 3 Months | 93.7 | 88.3 to 96.7 | 126 |
Hep A | ≥2 Doses | States/Local Areas | New Hampshire | 2021 | Age | 19 Months | 31.7 | 23.2 to 41.7 | 126 |
PCV | ≥4 Doses | States/Local Areas | New Hampshire | 2021 | Age | 35 Months | 86.2 | 77.8 to 92.6 | 126 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 89.1 | 80.1 to 95.2 | 126 |
Polio | ≥3 Doses | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 94.2 | 88.9 to 97.5 | 126 |
Polio | ≥1 Dose | States/Local Areas | New Hampshire | 2021 | Age | 3 Months | 91.6 | 85.0 to 95.4 | 126 |
≥1 Dose MMR | null | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 96.6 | 93.2 to 98.6 | 126 |
Hib | ≥3 Doses | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 89.9 | 81.6 to 95.5 | 126 |
Hib | Primary Series | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 92 | 84.8 to 96.6 | 126 |
Hib | ≥1 Dose | States/Local Areas | New Hampshire | 2021 | Age | 3 Months | 91.5 | 84.9 to 95.3 | 126 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2020-2021 | Age | 35 Months | 94.6 | 91.2 to 97.1 | 315 |
DTaP | ≥4 Doses | States/Local Areas | New Hampshire | 2021 | Age | 19 Months | 78.7 | 68.5 to 86.3 | 126 |
Hib | Full Series | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 82.4 | 73.0 to 90.0 | 126 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2021 | Age | 19 Months | 91.5 | 83.4 to 95.9 | 126 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2021 | Age | 7 Months | 78.6 | 68.8 to 86.0 | 126 |
≥1 Dose Varicella | null | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 93.3 | 86.9 to 97.3 | 126 |
PCV | ≥4 Doses | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 86.2 | 77.8 to 92.6 | 126 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 92.3 | 85.2 to 96.8 | 126 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2020-2021 | Age | 35 Months | 96.4 | 93.1 to 98.4 | 315 |
Hib | ≥3 Doses | States/Local Areas | New Hampshire | 2020-2021 | Age | 13 Months | 90.9 | 85.7 to 94.3 | 315 |
Hep A | ≥1 Dose | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 92.3 | 85.7 to 96.6 | 126 |
Hep A | ≥2 Doses | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 46.7 | 36.7 to 58.0 | 126 |
DTaP | ≥3 Doses | States/Local Areas | New Hampshire | 2021 | Age | 19 Months | 95 | 90.2 to 97.5 | 126 |
Hep B | ≥3 Doses | States/Local Areas | New Hampshire | 2020-2021 | Age | 24 Months | 95.5 | 92.5 to 97.5 | 315 |
PCV | ≥3 Doses | States/Local Areas | New Hampshire | 2021 | Age | 7 Months | 70 | 59.6 to 78.7 | 126 |
Combined 7 Series | null | States/Local Areas | New Hampshire | 2021 | Age | 24 Months | 77.2 | 67.6 to 85.6 | 126 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.